Hvis topotecan anvendes under graviditet, eller hvis graviditet indtræder under behandling med topotecan, skal patientern advares om den potentielle riskiko for barnet.
If topotecan is used during pregnancy, or if the patient becomes pregnant during therapy with topotecan, the patient must be warned of the potential hazards to the foetus.